Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
E Public Meeting Agenda Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems An Information-Gathering Workshop National Academy of Sciences Building Room 120 2101 Constitution Avenue, NW Washington, DC 20418 AGENDA Tuesday, February 21, 2017 8:45 AM Welcome and Opening Remarks David Eaton, Committee Chair Understanding Vaping: Who, What, and Why 9:00 User and Retailer Perspective Spike Babaian, VapeNY 9:20 Insights from Qualitative Research Jennifer Alexander, RTI 9:40 Patterns of Use and Disparities Daniel Giovenco, Mailman School of Public Health, Columbia University 10:00 Role of Flavorings in Sensory Perceptions of ENDS Paul Wise, Monell Center 10:20 Panel Discussion and Q&A 10:45 Break 741
742 PUBLIC HEALTH CONSEQUENCES OF E-CIGARETTES Systematic Reviews: Methodology and Lessons Learned 11:00 Integrating In Vitro and In Vivo Data Jon Samet, University of Southern California (via WebEx) 11:20 Human Health Effects Allison Glasser and Ray Niaura, Truth Initiative 11:40 Discussion and Q&A 12:00 PM Lunch Available in Cafeteria (lower level) Preclinical and Clinical Testing of ENDS 1:00 AEMSA Standards Lou Ritter, American E-Liquid Manufacturing Standards Association 1:15 Key Variables Important in Assessing ENDS Devices John Bellinger, Evolv Inc. 1:35 Key Variables Important in Assessing E-Liquids Kurt Kistler, The Pennsylvania State University, Brandywine 1:55 Clinical Studies in ENDS Users James Murphy, British American Tobacco 2:15 Particle Deposition Kirsten Koehler, Johns Hopkins Bloomberg School of Public Health 2:35 In Vitro Models Available for Testing of ENDS Holger Behrsing, Institute for In Vitro Sciences, Inc. 2:55 Results from In Vitro Assays Marianna GaÃ§a, British American Tobacco 3:15 Panel Discussion and Q&A 3:45 Break
APPENDIX E 743 Use of Population Dynamic Models to Understand the Population Health Effects of ENDS: Data Gaps and Uncertainties 4:00 Population Dynamic Modeling Eric Vugrin, Sandia National Labs 4:20 Panel Discussion Annette Bachand, Environ Rafael Meza, University of Michigan David Levy, Georgetown University 5:00 Public Comment 5:15 Adjourn Wednesday, February 22, 2017 Human Studies of ENDS Exposure 9:30 AM Virtual Session: Functional Changes in Airway Resistance and Inflammatory Cytokine Profiles After Human ENDS Exposures Pam Dalton, Monell Center (via WebEx) 10:00 Closed Session Resumes